Acute myeloid & lymphoblastic leukemia - causes, symptoms & pathology
What is acute leukemia? Well, it's a condition where the hematopoietic stem cells in the body become abnormal and accumulate in the bone marrow and blood ...
Osmosis
Role of Immunotherapy for the Treatment of Hematological Malignancies
Dr. Patrick Stiff, Director of the Cardinal Bernardin Cancer Center and Coleman Professor of Oncology at the Loyola University Medical Center, presented this ...
Leukemia Research Foundation
Hematological malignancies – Part 1b: Myeloproliferative Neoplasms and Myelodysplastic Syndromes
Myeloid leukemias and myeloproliferative and myelodysplastic disorders share common developmental features. In myeloproliferative neoplasms, there is an ...
AMBOSS: Medical Knowledge Distilled
2016 ASH Meeting on Hematologic Malignancies
Attend the ASH® Meeting on Hematologic Malignancies to hear the top experts in malignant hematology discuss the latest developments in clinical care, and ...
American Society of Hematology
Emerging targeted therapies in haematological malignancies
At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Julie M. Vose, MD, MBA, of the University of Nebraska Medical Center, Omaha, NE, ...
EMG-Health
ICAHO19 - Hematologic malignancies: Acute leukemia (new updates)
Dr. Roland Walter, a hematologist/oncologist from Seatlle Cancer Care Alliance speaks on leukemia at the 7th International Conference on Advances in ...
Binaytara Foundation
Update: New Drugs for AML
Earn CME: https://naccme.com/program/7331 In this presentation from the 'Looking to the Future With Hope: Advances in the Treatment of AML' symposium at ...
ImedexCME
Allogeneic therapy for the treatment of refractory hematological malignancies
There has been an increase in the number of patients with refractory hematological malignancies being referred to transplant centers, although previously, ...
VJHemOnc – Video Journal of Hematological Oncology
Future challenges facing hematological malignancies
Robin Foà, MD from Sapienza University of Rome, Rome, Italy highlights the major challenges that patients, scientists and doctors will face in the future when ...
VJHemOnc – Video Journal of Hematological Oncology
Cell Therapy & Hematologic Malignancies Specialist: Anthony D. Sung, MD
Cell therapy & hematologic malignancies specialist Anthony D. Sung, MD practices at the Duke Adult Blood and Marrow Transplant Clinic. Get to know him in ...
Duke Health
Julian Adams, PhD, Gives an Overview of the Treatment of Hematologic Malignancies
Julian Adams, PhD, President, Research and Development, Infinity Pharmaceuticals, gives an overview of the treatment of hematologic malignancies. For more ...
Targeted Oncology
Robin Foà MD, EHA 2019 – CAR-T Cells in the Treatment of Haematological Malignancies
At the EHA annual meeting in Amsterdam, Editorial Board member Robin Foà joins us to discuss the latest initiatives surrounding CAR-T cells and their use in ...
Touch Medical Media
CAR T-cells in hematological malignancies
Stephen Robinson, MBBS, MRCP, MRCPath, PhD, of University Hospitals Bristol NHS Foundation Trust, Bristol, UK, speaks to us about one of the most exciting ...
VJHemOnc – Video Journal of Hematological Oncology
New targets for hematological malignancy therapies
Olaf Heidenreich, PhD from Newcastle University, Newcastle, UK discusses what he finds most exciting about the new treatments in cancer and hematology.
VJHemOnc – Video Journal of Hematological Oncology
Pre-Conference Perspectives on Hematologic Malignancies
Expert panelists John Leonard, MD; Ola Landgren, MD; Alexander Perl, MD; and Anas Younes, MD, discuss the latest advances in treating hematologic ...
OncLiveTV
Immunomodulation of NK cells for the treatment of lymphoid malignancies
This outstanding webcast of the Lymphoma & Myeloma 2013, an International Congress on Hematologic Malignancies, includes experts presenting the current ...
ImedexCME
COVID-19 & Hematologic Malignancies: Episode 5 - Patient Experience Update
Earn CME: https://www.naccme.com/program/20-hemcovid-5 In this webcast, Drs. Joseph R. Mikhael and patient advocate Yelak Biru discuss ways to limit ...
ImedexCME
Advances in Treatments for Hematologic Malignancies Pt. 2 - Sarah Cannon
Dr. Ian Flinn from the Sarah Cannon Research Institute, Nashville, USA, talks to ecancer.TV about new clinical research presented at ASH 2012 from his ...
Sarah Cannon Cancer Network
Promising results for venetoclax across multiple hematological malignancies
Venetoclax is making headlines due to its effectiveness against many hematological cancers. In this video, Giovanni Martinelli, MD, of the Istituto Scientifico ...
VJHemOnc – Video Journal of Hematological Oncology
How CAR T-Cell Therapy Has Evolved in Hematologic Malignancies
Frederick L. Locke, MD, medical director and research director of the Immune Cell Therapy Program and the co-program leader of the Immunology Program, ...
Targeted Oncology
Microbiota in hematologic malignancies
Florent Malard, MD, PhD, Saint-Antoine Hospital, Paris, France, tells us what he's looking forward to at EHA 2020. Prof. Malard highlights a study on the role of ...
VJHemOnc – Video Journal of Hematological Oncology
ASH Meeting on Hematologic Malignancies: Irene Ghobrial, MD
ASH Meeting on Hematologic Malignancies speaker Irene Ghobrial, MD, shares how the ASH Meeting on Hematologic Malignancies will incorporate basic and ...
American Society of Hematology
Competence in Cancer Care: Hematologic Malignancies
CE available at www.noep.org. This CNE activity is grant funded by the Cancer Prevention and Research Institute of Texas, PP120177.
NurseOEP
New approaches to Hairy Cell Leukemia
In this presentation from the 2017 Great Debates & Updates in Hematologic Malignancies, Dr. Jae Park discusses new approaches to the treatment of hairy cell ...
ImedexCME
Pre-Conference Perspectives on Hematologic Malignancies
Expert panelists John Leonard, MD; Ola Landgren, MD; Alexander Perl, MD; and Anas Younes, MD, discuss the latest advances in treating hematologic ...
OncLiveTV
Immunotherapy Response Among Hematologic Malignancies
Panelists Andre Goy, MD, MS; Krishna V. Komanduri, MD; Ian W. Flinn, MD; and Frederick L. Locke, MD, provide insight on the role of tumor-infiltrating ...
OncLiveTV
ASH Meeting on Hematologic Malignancies: David Steensma, MD
ASH Meeting on Hematologic Malignancies speaker David Steensma, MD, discusses the most promising areas of investigation in myelodysplastic syndromes ...
American Society of Hematology
HARMONY: Enabling better and faster treatment for patients with haematological malignancies
Lars Bullinger, MD, from the University Hospital of Ulm, Ulm, Germany, talks to us about HARMONY: An EU project in hematology, enabling a better and faster ...
VJHemOnc – Video Journal of Hematological Oncology
Anticoagulation Management and Difficult Cases
Filmed on location in New York during the Great Debates & Updates in Hematologic Malignancies 2015, this webcast is part of a series that focuses on ...
ImedexCME
Dr. Shuo Ma on Non-chemotherapy Regimens for Hematologic Malignancies
OncLiveTV
Dr. Perales on the PROGRESS II Trial in Hematologic Malignancies
Miguel-Angel Perales, MD, deputy chief, Adult Bone Marrow Transplant Service, director, Adult Bone Marrow Transplantation Fellowship Program, Memorial ...
OncLiveTV
Hematologic Malignancies & Bone Marrow Transplantation Program at UT Southwestern
The Hematologic Malignancies & Bone Marrow Transplantation Program at UT Southwestern provides excellent, compassionate care for patients with all types ...
UTSWMed
New trends in the management of leukemia
At the 58th American Society of Hematology (ASH) Annual Meeting & Exposition, Robin Foà, MD, from Sapienza University, Rome, Italy, summarises major ...
VJHemOnc – Video Journal of Hematological Oncology
Julian Adams on the IPI-145 Mechanism of Action in Hematologic Malignancies
Julian Adams, PhD, the president of research and development at Infinity Pharmaceuticals, describes the mechanism of action for the experimental PI3K ...
OncLiveTV
Dr. Koprivnikar Discusses FLT3 Inhibitors in Hematologic Malignancies
OncLiveTV
Debate: Young patient with recurrent follicular lymphoma and short remission? - Novel agents/chemo
In this presentation from the Great Debates & Updates in Hematologic Malignancies 2018 conference, Dr. Grzegorz S. Nowakowski argues in favor of the use of ...
ImedexCME
Dr. Andreadis on Developments to CAR T-Cell Therapy
Charalambos (Babis) Andreadis, MD, MSCE, associate professor of clinical medicine, Department of Medicine, UCSF Helen Diller Family Comprehensive ...
OncLiveTV
Dr. Flinn Discusses IPI-145 as Potential Treatment for Hematologic Malignancies
Ian W. Flinn, MD, PhD, director, Hematologic Malignancies Research Program, Sarah Cannon Research Institute, discusses IPI-145, an oral inhibitor of ...
OncLiveTV
Dr. Usmani on PD-1/PD-L1 Inhibitors in Hematologic Malignancies
Saad Z. Usmani, MD, clinical professor of medicine, UNC-Chapel Hill School of Medicine, chief, Plasma Cell Disorders Program, director, clinical research in ...
OncLiveTV
Dr. Garfall on Impact of CAR T-Cell Therapy in Hematologic Malignancies
Alfred L. Garfall, MD, MS, assistant professor of Medicine, the Hospital of the University of Pennsylvania, discusses the impact of chimeric antigen receptor (CAR) ...
OncLiveTV
The development of novel treatment modalities: regulations and expectations
Novel technologies have the potential to allow us to treat more ailments, but often come at the price of new toxicities. Speaking from the International Conference ...
VJHemOnc – Video Journal of Hematological Oncology
Key Insights: Multiple Myeloma
The continued evolution and refinement of strategies for disease diagnosis, risk assessment, therapeutic intervention and disease management have provided ...
ImedexCME
